← Evidence map

ArticlePharmacology research & perspectives2023

Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab.

B Miguel-Lillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37920875